Therapeutic use of a recombinant erythropoietin having high activity and reduced side effects

Details for Australian Patent Application No. 2001291755 (hide)

Owner Baxter Healthcare S.A.

Inventors Thompson, Lawrence H.

Agent Peter Maxwell & Associates

Pub. Number AU-B-2001291755

PCT Pub. Number WO02/14356

Priority 09/637,962 11.08.00 US

Filing date 9 August 2001

Wipo publication date 25 February 2002

Acceptance publication date 18 May 2006

International Classifications

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

Event Publications

18 May 2006 Application Accepted

  Published as AU-B-2001291755

14 September 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001291756

2001291754-Camera stand head